131 related articles for article (PubMed ID: 773334)
21. Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract.
Seppälä M; Pihko H; Ruoslahti E
Cancer; 1975 May; 35(5):1377-81. PubMed ID: 47262
[TBL] [Abstract][Full Text] [Related]
22. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
[TBL] [Abstract][Full Text] [Related]
23. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
Lewkonia RM; Kerr EJ; Irvine WJ
Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
[TBL] [Abstract][Full Text] [Related]
25. Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations.
Nalick RH; DiSaia PJ; Rea TH; Morrow MH
Am J Obstet Gynecol; 1974 Feb; 118(3):393-405. PubMed ID: 4358924
[No Abstract] [Full Text] [Related]
26. Immunocompetence and prognosis in patients with gynecologic cancer.
Nalick RH; Disaia PJ; Rea TH; Morrow CP
Gynecol Oncol; 1974 Apr; 2(1):81-92. PubMed ID: 4459211
[No Abstract] [Full Text] [Related]
27. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
Miuller M; Irmsher Iu; Fisher R; Grosmann G
Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
[TBL] [Abstract][Full Text] [Related]
28. Urine excretion of tumor-associated antigens by patients with gynecologic neoplasms.
Rote NS; Smith WG; Johnson GH
Gynecol Oncol; 1980 Jun; 9(3):370-5. PubMed ID: 6991377
[No Abstract] [Full Text] [Related]
29. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
[TBL] [Abstract][Full Text] [Related]
30. Carcinoembryonic antigen in cancer of the female reproductive system. Serial plasma values correlated with disease state.
DiSaia PJ; Morrow CP; Haverback BJ; Dyce BJ
Cancer; 1977 Jun; 39(6):2365-70. PubMed ID: 194665
[TBL] [Abstract][Full Text] [Related]
31. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
[No Abstract] [Full Text] [Related]
32. The linoleic acid depression (LAD) test for multiple sclerosis using the macrophage electrophoretic mobility (MEM) test.
Jenssen HL; Meyer-Rienecker HJ; Köhler H; Günther JK
Acta Neurol Scand; 1976 Jan; 53(1):51-60. PubMed ID: 1251680
[TBL] [Abstract][Full Text] [Related]
33. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
34. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
Ferguson A; Moore M; Fox H
Br J Cancer; 1985 Oct; 52(4):551-63. PubMed ID: 2415145
[TBL] [Abstract][Full Text] [Related]
35. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
Malkovský M; Bubeník J; Holán V; Hasek M
Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
[TBL] [Abstract][Full Text] [Related]
36. On the mechanism of binding of human lymphocyte products to guinea pig macrophages.
Weiss L; Harlos JP; Subjeck JR
Cell Biophys; 1979 Mar; 1(1):65-77. PubMed ID: 95169
[TBL] [Abstract][Full Text] [Related]
37. [Electrophoresis mobility inhibition test (emt) in immunological early diagnosis of gynaecological malignomas (author's transl)].
Kreienberg R; Schütz G; Melchert F; Lemmel EM
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):709-15. PubMed ID: 383565
[TBL] [Abstract][Full Text] [Related]
38. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
Ressel M; Köhler G
Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
[TBL] [Abstract][Full Text] [Related]
39. Immunologic reactivity of female patients with genital cancer: status in preinvasive, locally invasive, and disseminated disease.
Khoo SK; Mackay EV
Am J Obstet Gynecol; 1974 Aug; 119(8):1018-25. PubMed ID: 4603198
[No Abstract] [Full Text] [Related]
40. Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) test.
Pasternak L; Jenssen HL; Köhler H; Pasternak G
Eur J Cancer (1965); 1976 May; 12(5):389-93. PubMed ID: 954796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
